Benitec Biopharma Inc. · Brief

Next report

14 days

Nov 16 · after closeest.Q1 FY27

Expected move

No implied move.

8 reportsHistory

0 of 6≥ implied

Nov 14 '24—▲+2.69%—

Feb 14 '25—▲+15.98%—

May 14 '25±14.4%▲+3.03%×0.21

Q1 FY26±29.5%▼−2.15%×0.07

Nov 14 '25±33.2%▲+2.81%×0.08

Feb 12 '26±42.4%▼−2.66%×0.06

Q3 FY26±46.8%▲+1.72%×0.04

Sep 14 '26±33.9%▼−8.53%×0.25

quarterimplied−50%0+50%realized×

Sep '26±33.9%▼−8.53%×0.25

Q3 FY26±46.8%▲+1.72%×0.04

Feb '26±42.4%▼−2.66%×0.06

Nov '25±33.2%▲+2.81%×0.08

Q1 FY26±29.5%▼−2.15%×0.07

May '25±14.4%▲+3.03%×0.21

2 older reports

Feb '25—▲+15.98%—

Nov '24—▲+2.69%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 16 report · est.

Bull2 of 3

3tracked funds holding BNTCN-PORT · Aug 31 '26

86managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2

0.01%of iShares Russell 2000 ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26

5 of 24largest reporting managers that cut their stake in the latest quarter13F · Jun 30 '26

AI captions · Sep 28 '26once per report · top 2 per case

BNTC report session

No linked exposure.

No changes.

privateThesis 0 · Decisions 0 · Observations 0

No thesis.